Pulse Lab
Pulse Lab is a privately held, Singapore-domiciled company founded in 2017 with a five-person team; its public website exposes only a verification page, and no products, services, revenue, or customers are disclosed in the available source data.
- Company typePrivate
- Founded2017
- HeadquartersSingapore, Singapore
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Pulse Lab does
Pulse Lab is a privately held company domiciled in Singapore, founded in 2017. As of the latest available data, the firm has a headcount of five employees and operates from Singapore under the domain pulselab.sg. Beyond these firmographic facts, the source data provides no information on the company's products, services, target customers, technology stack, or commercial activity.
The publicly accessible web presence for Pulse Lab consists only of a verification/loading page ("One moment, please… Please wait while your request is being verified"), with no substantive content describing the business. The structured data fields for products, technology, pricing, customers, partnerships, awards, management team, funding rounds, and revenue are all empty, and no patents, certifications, integrations, or AI-related capabilities are documented. There are no disclosed investors, parent entities, or subsidiaries, and no public ticker or listing is indicated.
Given the absence of any disclosed operational, financial, or product information in the available source material, any characterization of Pulse Lab's business model, revenue mechanics, customer base, or strategic direction is unsupported. The company is best described at this point as a small, Singapore-registered private entity of unknown operating status and undisclosed commercial activity, with a public web surface that does not currently expose product or service information.
Pulse Lab firmographics
Firmographics- Name
- Pulse Lab
- Website
- https://pulselab.sg
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Pulse Lab is a privately held, Singapore-domiciled company founded in 2017 with a five-person team; its public website exposes only a verification page, and no products, services, revenue, or customers are disclosed in the available source data.
- Ownership category
- akta.pro rank
Pulse Lab industry classification
Industry- Product category
- Unable to determine from source data
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG) (HLAGAAAJ)
Where Pulse Lab is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Markets served
Pulse Lab business model
Business model- GTM type
- B2B
- Offering type
- Services
Pulse Lab product offering
Product offeringCore offering
Unable to determine from source data. The aggregated material contains no description of Pulse Lab's actual offerings; the website at pulselab.sg renders only a verification/loading page with no product or service content, and the firmographic and product dossiers list empty products, empty product_overview, empty core_technology, and empty proprietary_features fields.
Differentiator
Problem solved
Functional benefit
Pulse Lab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pulse Lab competitors and assessment
Company assessmentBroad incumbents
- Medpace: Medpace is a mid-to-large CRO offering cardiac safety and ECG core lab capabilities among its broader clinical research services. Comparable to a small cardiac-focused lab as a broader incumbent that bundles core lab services with full-service CRO delivery.
- Labcorp Drug Development (Fortrea): Fortrea (formerly Labcorp Drug Development) provides central laboratory and cardiac safety services to clinical trials globally. Comparable as a broad incumbent whose central lab services overlap with the inferred Pulse Lab offering.
- IQVIA: IQVIA is one of the largest global CROs with extensive cardiac safety and clinical laboratory capabilities. Comparable as a broad incumbent that dwarfs any small specialty core lab in scale and sponsor access.
- BioTelemetry (Philips): BioTelemetry, acquired by Philips, provides cardiac monitoring and centralized ECG services relevant to clinical trials and remote patient monitoring. Comparable as a large incumbent in cardiac monitoring/ECG services adjacent to the inferred Pulse Lab focus.
- ERT (Clario): Clario (formerly ERT) is a leading provider of cardiac safety and clinical endpoint technology for clinical trials, including ECG core lab services. It is comparable to Pulse Lab to the extent Pulse Lab operates in cardiac safety core lab / ECG services, representing the dominant incumbent in the inferred niche.
- Bioclinica (Clario): Now part of Clario, Bioclinica historically provided imaging and cardiac core lab services for clinical trials. Comparable as a large incumbent in cardiac safety core lab services relevant to a "Pulse Lab" type offering.
Regional players
- Cardiac Safety Singapore / regional Asian CRO core labs: Regional Asian CROs and cardiac safety labs in the APAC region serve similar customers (trial sponsors) and would compete for the same APAC-anchored cardiac core lab work that a Singapore-based Pulse Lab might pursue. Comparable as a regional peer for APAC-based delivery.
Direct peers
- Banook Group: Banook Group is a specialized cardiac safety services provider offering centralized ECG, imaging, and event adjudication for clinical trials. Comparable as a direct peer if Pulse Lab operates in cardiac core lab services, with similar service-line focus.
Market position
Strengths2 records
Weaknesses3 records
Key highlights3 records
Customer concentration
Pulse Lab social profiles
Digital presencePulse Lab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pulse Lab leadership team
Management profileNumber of profiles
Pulse Lab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pulse Lab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pulse Lab
What does Pulse Lab do?
Unable to determine from source data. The aggregated material contains no description of Pulse Lab's actual offerings; the website at pulselab.sg renders only a verification/loading page with no product or service content, and the firmographic and product dossiers list empty products, empty product_overview, empty core_technology, and empty proprietary_features fields.
Is Pulse Lab a public or private company?
Pulse Lab is a private company. It is classified as unknown and is currently operating.
When was Pulse Lab founded?
Pulse Lab was founded in 2017. It employs 1 to 10 people.
Where is Pulse Lab based?
Pulse Lab is headquartered in Singapore, Singapore, in the Asia region.
Who are Pulse Lab's main competitors?
Broad incumbents on record are Medpace, Labcorp Drug Development (Fortrea), IQVIA, BioTelemetry (Philips), ERT (Clario) and Bioclinica (Clario). Cardiac Safety Singapore / regional Asian CRO core labs is listed as a regional player. Banook Group is listed as a direct peer.
Does Pulse Lab have an API?
No public API is recorded for Pulse Lab.
What industry is Pulse Lab in?
Pulse Lab's product category is Unable to determine from source data. Its primary akta.pro industry code is HLAGAAAJ, Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG). Its NAICS code is 621511 and its SIC code is 8071.